You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 14, 2025

Drugs Containing Excipient (Inactive Ingredient) MICROCRYSTALLINE CELLULOSE 301


✉ Email this page to a colleague

« Back to Dashboard


Generic drugs containing MICROCRYSTALLINE CELLULOSE 301 excipient

Microcrystalline Cellulose 301: Market Dynamics and Financial Trajectory

Introduction to Microcrystalline Cellulose 301

Microcrystalline cellulose (MCC) 301, such as MICROCEL® 301 SD, is a highly versatile excipient widely used in the pharmaceutical, food, and personal care industries. It is derived from natural cellulose sources, including wood pulp or cotton, and is renowned for its exceptional binding, disintegration, and flow properties[3][4].

Market Size and Growth

The global microcrystalline cellulose market, which includes MCC 301, has been experiencing significant growth. As of 2022, the market size stood at approximately $1.2 billion. It is projected to grow at a Compound Annual Growth Rate (CAGR) of 7.0% from 2023 to 2031, reaching $2.1 billion by the end of the forecast period[1][4].

Drivers of Market Growth

Several factors are driving the growth of the microcrystalline cellulose market:

Increasing Demand in Pharmaceuticals

The pharmaceutical sector is the largest consumer of MCC, driven by its multifunctional properties as a binder, filler, and disintegrant in tablet formulations. The rising demand for pharmaceutical products, particularly in emerging economies, is a significant driver[3][5].

Growing Health and Wellness Trends

The increasing awareness of health and wellness among consumers has led to a surge in demand for dietary supplements. MCC's inert nature and binding properties make it an ideal ingredient in these supplements[1].

Sustainability and Eco-Friendliness

MCC is derived from renewable sources such as wood pulp, aligning with the global push for sustainable and eco-friendly products. This appeal to sustainability is a major catalyst for its expansion[1][5].

Technological Innovations

Advances in production techniques are improving the cost-efficiency and performance of MCC. These innovations are expected to stimulate further market growth[5].

End-Use Applications

MCC 301 is versatile and finds extensive application in various industries:

Pharmaceutical Industry

In pharmaceuticals, MCC 301 is used as a direct compression excipient for oral dosage forms. It functions as a stabilizing agent and expanding agent, enhancing the stability and efficacy of tablets[2][3].

Food and Beverages

In the food industry, MCC is used as a fat substitute and texture modifier. Its ability to improve the texture and stability of food products makes it a valuable ingredient[3].

Personal Care

In personal care products, MCC is used in cosmetics and skincare formulations due to its inert and non-reactive nature, making it suitable for a wide range of applications[3].

Regional Analysis

The market for microcrystalline cellulose is geographically diverse, with key regions including:

North America

North America, particularly the United States, holds a significant market share. The region is expected to maintain its dominance due to the strong presence of pharmaceutical and food industries[4][5].

Europe

Europe is another major market, driven by stringent regulatory standards and a high demand for pharmaceutical and food products[4].

Asia Pacific

The Asia Pacific region, including countries like China, is experiencing rapid industrial growth, presenting substantial growth opportunities for MCC. Emerging economies in this region are driving the demand for pharmaceuticals, food, and personal care products[5].

Market Attractiveness and Competition

The market attractiveness of MCC is high due to its multifunctional properties and alignment with key consumer trends. The competition landscape is characterized by strategic alliances and partnerships among manufacturers to increase production capacity and meet the growing demand. This increased manufacturing capacity is expected to positively impact the overall efficiency of the supply chain, leading to price stability and a more dependable supply of MCC[3][4].

Economic Recovery Post COVID-19

The COVID-19 pandemic had a significant impact on the supply chain of microcrystalline cellulose, but the market is showing signs of recovery. The increased demand for pharmaceuticals and health supplements during the pandemic has accelerated the recovery process. Manufacturers are now focusing on augmenting their production capabilities to meet the rising demand[4].

Key Takeaways

  • Market Growth: The global microcrystalline cellulose market is expected to grow at a CAGR of 7.0% from 2023 to 2031, reaching $2.1 billion.
  • Drivers: Increasing demand in pharmaceuticals, health and wellness trends, sustainability, and technological innovations are key drivers.
  • End-Use Applications: MCC 301 is widely used in pharmaceuticals, food and beverages, and personal care.
  • Regional Analysis: North America, Europe, and the Asia Pacific are significant markets, with emerging economies driving growth.
  • Market Attractiveness: High due to multifunctional properties and alignment with consumer trends.

FAQs

What is microcrystalline cellulose 301 used for?

Microcrystalline cellulose 301 is used as a direct compression excipient in pharmaceutical oral dosage forms, as a fat substitute in food products, and in personal care formulations due to its binding, disintegration, and flow properties.

What are the key drivers of the microcrystalline cellulose market?

The key drivers include increasing demand in the pharmaceutical sector, growing health and wellness trends, the appeal of sustainability, and technological innovations in production.

How is the microcrystalline cellulose market expected to grow?

The market is expected to grow at a CAGR of 7.0% from 2023 to 2031, reaching $2.1 billion by 2031.

Which regions are significant in the microcrystalline cellulose market?

North America, Europe, and the Asia Pacific are significant regions, with emerging economies in the Asia Pacific driving substantial growth.

How has the COVID-19 pandemic impacted the microcrystalline cellulose market?

The pandemic impacted the supply chain, but the market is recovering with increased demand for pharmaceuticals and health supplements. Manufacturers are augmenting their production capabilities to meet the rising demand.

What are the benefits of using microcrystalline cellulose in pharmaceutical formulations?

MCC provides exceptional binding, disintegration, and flow properties, making it an ideal excipient for tablet formulations. It also aligns with the trend towards sustainable and eco-friendly products.

Sources

  1. Transparency Market Research Inc. - Microcrystalline Cellulose Market to Cross USD 2.1 billion at a CAGR of 7.0% by 2031[1].
  2. Roquette - MICROCEL® 301 SD Microcrystalline Cellulose[2].
  3. Persistence Market Research - Microcrystalline Cellulose Market Size & Share Report, 2030[3].
  4. Transparency Market Research - Microcrystalline Cellulose Market Size, Statistics Report, 2031[4].
  5. GlobeNewswire - Microcrystalline Cellulose Market to Reach USD 1,794.1 Million by 2033[5].

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.